These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1960 related articles for article (PubMed ID: 32505227)

  • 1. Immunology of COVID-19: Current State of the Science.
    Vabret N; Britton GJ; Gruber C; Hegde S; Kim J; Kuksin M; Levantovsky R; Malle L; Moreira A; Park MD; Pia L; Risson E; Saffern M; Salomé B; Esai Selvan M; Spindler MP; Tan J; van der Heide V; Gregory JK; Alexandropoulos K; Bhardwaj N; Brown BD; Greenbaum B; Gümüş ZH; Homann D; Horowitz A; Kamphorst AO; Curotto de Lafaille MA; Mehandru S; Merad M; Samstein RM;
    Immunity; 2020 Jun; 52(6):910-941. PubMed ID: 32505227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
    Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
    J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI).
    Sokolowska M; Lukasik ZM; Agache I; Akdis CA; Akdis D; Akdis M; Barcik W; Brough HA; Eiwegger T; Eljaszewicz A; Eyerich S; Feleszko W; Gomez-Casado C; Hoffmann-Sommergruber K; Janda J; Jiménez-Saiz R; Jutel M; Knol EF; Kortekaas Krohn I; Kothari A; Makowska J; Moniuszko M; Morita H; O'Mahony L; Nadeau K; Ozdemir C; Pali-Schöll I; Palomares O; Papaleo F; Prunicki M; Schmidt-Weber CB; Sediva A; Schwarze J; Shamji MH; Tramper-Stranders GA; van de Veen W; Untersmayr E
    Allergy; 2020 Oct; 75(10):2445-2476. PubMed ID: 32584441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
    Prete M; Favoino E; Catacchio G; Racanelli V; Perosa F
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19: The Immune Responses and Clinical Therapy Candidates.
    Zhand S; Saghaeian Jazi M; Mohammadi S; Tarighati Rasekhi R; Rostamian G; Kalani MR; Rostamian A; George J; Douglas MW
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapulmonary manifestations of COVID-19.
    Gupta A; Madhavan MV; Sehgal K; Nair N; Mahajan S; Sehrawat TS; Bikdeli B; Ahluwalia N; Ausiello JC; Wan EY; Freedberg DE; Kirtane AJ; Parikh SA; Maurer MS; Nordvig AS; Accili D; Bathon JM; Mohan S; Bauer KA; Leon MB; Krumholz HM; Uriel N; Mehra MR; Elkind MSV; Stone GW; Schwartz A; Ho DD; Bilezikian JP; Landry DW
    Nat Med; 2020 Jul; 26(7):1017-1032. PubMed ID: 32651579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The trinity of COVID-19: immunity, inflammation and intervention.
    Tay MZ; Poh CM; Rénia L; MacAry PA; Ng LFP
    Nat Rev Immunol; 2020 Jun; 20(6):363-374. PubMed ID: 32346093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SnapShot: COVID-19.
    Oberfeld B; Achanta A; Carpenter K; Chen P; Gilette NM; Langat P; Said JT; Schiff AE; Zhou AS; Barczak AK; Pillai S
    Cell; 2020 May; 181(4):954-954.e1. PubMed ID: 32413300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
    Schijns V; Lavelle EC
    Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe COVID-19 disease and thromboinflammation.
    Jerjes-Sánchez C
    Arch Cardiol Mex; 2020; 90(3):257-258. PubMed ID: 32952161
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.
    Wauters E; Thevissen K; Wouters C; Bosisio FM; De Smet F; Gunst J; Humblet-Baron S; Lambrechts D; Liston A; Matthys P; Neyts J; Proost P; Weynand B; Wauters J; Tejpar S; Garg AD
    Front Immunol; 2020; 11():1642. PubMed ID: 32719686
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    Nowill AE; de Campos-Lima PO
    J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The many faces of the anti-COVID immune response.
    Vardhana SA; Wolchok JD
    J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32353870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
    Huizinga GP; Singer BH; Singer K
    Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
    Amor S; Fernández Blanco L; Baker D
    Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
    Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
    FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.
    Zhou T; Su TT; Mudianto T; Wang J
    J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32910820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.
    Kumar V
    Int Immunopharmacol; 2020 Nov; 88():106980. PubMed ID: 33182073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
    Netea MG; Giamarellos-Bourboulis EJ; Domínguez-Andrés J; Curtis N; van Crevel R; van de Veerdonk FL; Bonten M
    Cell; 2020 May; 181(5):969-977. PubMed ID: 32437659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Insights into Immune Responses during COVID-19.
    St John AL; Rathore APS
    J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.